Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000093751-24-000095
Filing Date
2024-01-23
Accepted
2024-01-23 10:28:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 Nurix_Th_Inc.txt SC 13G/A 6448
  Complete submission text file 0000093751-24-000095.txt   8480
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

EIN.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)

Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Subject) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: SC 13G/A | Act: 34 | File No.: 005-91591 | Film No.: 24550863
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)